在老年人中治疗偏头痛的特殊考虑
Patricia A Olson1, Jonathan H Smith2, Joost Haan3
1Department of Neurology, University of Kentucky, Lexington, KY, United States.
Handbook of clinical neurology
|February 2, 2024
概括
老年患者的偏头痛管理需要个性化策略,因为与年龄相关的大脑变化和潜在的认知影响. 了解并发症和多药学对于有效治疗这种常见疾病至关重要.
科学领域:
- 神经学 神经学
- 老年病的医生 老年病的医生
背景情况:
- 老化的大脑表现出明显的变化,影响神经递质系统和疼痛通路,使偏头痛的诊断和管理复杂化.
- 老年人的偏头痛带来了独特的挑战,包括非典型的症状表现和需要个性化的治疗方法.
研究的目的:
- 解构老年人中偏头痛的定义,流行和管理.
- 突出诊断和治疗方面的挑战,包括并发症和认知影响.
主要方法:
- 文献综述和综合当前关于老年人口中偏头痛的知识.
- 讨论与偏头痛相关的老化大脑的生理变化.
主要成果:
- 偏头痛在老年人中并不罕见,经常呈现异常.
- 偏头痛不是痴呆症的危险因素,但治疗可能会影响认知.
结论:
- 个性化护理对于老年患者的偏头痛诊断和管理至关重要.
- 对非典型表现和潜在的认知影响的认识对于医疗保健提供者来说至关重要.
- 对于老年人来说,有效的偏头痛管理需要采用综合方法,考虑并发症和多药.
相关概念视频
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
62
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
62
Cholinergic Antagonists: Therapeutic Uses
749
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
749
Alzheimer's Disease: Treatment
193
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193
Open Angle Glaucoma: Treatment
452
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
452
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K


